174 related articles for article (PubMed ID: 21605971)
1. Identification of a novel cell binding site of periostin involved in tumour growth.
Orecchia P; Conte R; Balza E; Castellani P; Borsi L; Zardi L; Mingari MC; Carnemolla B
Eur J Cancer; 2011 Sep; 47(14):2221-9. PubMed ID: 21605971
[TBL] [Abstract][Full Text] [Related]
2. Role of periostin in cancer progression and metastasis: inhibition of breast cancer progression and metastasis by anti-periostin antibody in a murine model.
Kyutoku M; Taniyama Y; Katsuragi N; Shimizu H; Kunugiza Y; Iekushi K; Koibuchi N; Sanada F; Oshita Y; Morishita R
Int J Mol Med; 2011 Aug; 28(2):181-6. PubMed ID: 21617848
[TBL] [Abstract][Full Text] [Related]
3. A novel human anti-syndecan-1 antibody inhibits vascular maturation and tumour growth in melanoma.
Orecchia P; Conte R; Balza E; Petretto A; Mauri P; Mingari MC; Carnemolla B
Eur J Cancer; 2013 May; 49(8):2022-33. PubMed ID: 23352437
[TBL] [Abstract][Full Text] [Related]
4. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility.
Gillan L; Matei D; Fishman DA; Gerbin CS; Karlan BY; Chang DD
Cancer Res; 2002 Sep; 62(18):5358-64. PubMed ID: 12235007
[TBL] [Abstract][Full Text] [Related]
5. Periostin promotes ovarian cancer angiogenesis and metastasis.
Zhu M; Fejzo MS; Anderson L; Dering J; Ginther C; Ramos L; Gasson JC; Karlan BY; Slamon DJ
Gynecol Oncol; 2010 Nov; 119(2):337-44. PubMed ID: 20688362
[TBL] [Abstract][Full Text] [Related]
6. Role of integrins as signal transducing cell adhesion molecules in human cutaneous melanoma.
Danen EH; Van Muijen GN; Ruiter DJ
Cancer Surv; 1995; 24():43-65. PubMed ID: 7553662
[TBL] [Abstract][Full Text] [Related]
7. Regulation of tumor angiogenesis by fastatin, the fourth FAS1 domain of betaig-h3, via alphavbeta3 integrin.
Nam JO; Jeong HW; Lee BH; Park RW; Kim IS
Cancer Res; 2005 May; 65(10):4153-61. PubMed ID: 15899806
[TBL] [Abstract][Full Text] [Related]
8. Novel highly specific anti-periostin antibodies uncover the functional importance of the fascilin 1-1 domain and highlight preferential expression of periostin in aggressive breast cancer.
Field S; Uyttenhove C; Stroobant V; Cheou P; Donckers D; Coutelier JP; Simpson PT; Cummings MC; Saunus JM; Reid LE; Kutasovic JR; McNicol AM; Kim BR; Kim JH; Lakhani SR; Neville AM; Van Snick J; Jat PS
Int J Cancer; 2016 Apr; 138(8):1959-70. PubMed ID: 26619948
[TBL] [Abstract][Full Text] [Related]
9. Markers of melanocytic tumour progression.
Ruiter DJ; van Muijen GN
J Pathol; 1998 Dec; 186(4):340-2. PubMed ID: 10209480
[TBL] [Abstract][Full Text] [Related]
10. Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity.
Erkan M; Kleeff J; Gorbachevski A; Reiser C; Mitkus T; Esposito I; Giese T; Büchler MW; Giese NA; Friess H
Gastroenterology; 2007 Apr; 132(4):1447-64. PubMed ID: 17408641
[TBL] [Abstract][Full Text] [Related]
11. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
Sun LC; Luo J; Mackey LV; Fuselier JA; Coy DH
Cancer Lett; 2007 Feb; 246(1-2):157-66. PubMed ID: 16644105
[TBL] [Abstract][Full Text] [Related]
12. Suppression of mouse melanoma metastasis by EA-1, a monoclonal antibody specific for alpha 6 integrins.
Ruiz P; Dunon D; Sonnenberg A; Imhof BA
Cell Adhes Commun; 1993 May; 1(1):67-81. PubMed ID: 8081871
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta.
Horiuchi K; Amizuka N; Takeshita S; Takamatsu H; Katsuura M; Ozawa H; Toyama Y; Bonewald LF; Kudo A
J Bone Miner Res; 1999 Jul; 14(7):1239-49. PubMed ID: 10404027
[TBL] [Abstract][Full Text] [Related]
14. Clinical markers and driving mechanisms in melanoma progression: VEGF-C, RhoC, c-Ski/SnoN and EGFR.
Boone B; Brochez L
Verh K Acad Geneeskd Belg; 2009; 71(5):251-94. PubMed ID: 20232784
[TBL] [Abstract][Full Text] [Related]
15. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions.
Natali PG; Hamby CV; Felding-Habermann B; Liang B; Nicotra MR; Di Filippo F; Giannarelli D; Temponi M; Ferrone S
Cancer Res; 1997 Apr; 57(8):1554-60. PubMed ID: 9108459
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract][Full Text] [Related]
18. Beta ig-h3 mediates osteoblast adhesion and inhibits differentiation.
Thapa N; Kang KB; Kim IS
Bone; 2005 Feb; 36(2):232-42. PubMed ID: 15780949
[TBL] [Abstract][Full Text] [Related]
19. A NOD/SCID tumor model for human ovarian cancer that allows tracking of tumor progression through the biomarker Sp17.
Chiriva-Internati M; Grizzi F; Weidanz JA; Ferrari R; Yuefei Y; Velez B; Shearer MH; Lowe DB; Frezza EE; Cobos E; Kast WM; Kennedy RC
J Immunol Methods; 2007 Apr; 321(1-2):86-93. PubMed ID: 17336323
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of growth hormone receptor immunoreactivity in human melanoma.
Lincoln DT; Sinowatz F; Kölle S; Takahashi H; Parsons P; Waters M
Anticancer Res; 1999; 19(3A):1919-31. PubMed ID: 10470136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
